TFA Therapeutics, Inc. (RAJAF) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$534.6K | -42.3% |
| 2024 | -$375.5K | -147.4% |
| 2023 | -$151.8K | +84.0% |
| 2022 | -$951.3K | -244.9% |
| 2021 | -$275.8K | -2052.8% |
| 2020 | -$12.8K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$534.6K | -42.3% |
| 2024 | -$375.5K | -147.4% |
| 2023 | -$151.8K | +84.0% |
| 2022 | -$951.3K | -244.9% |
| 2021 | -$275.8K | -2052.8% |
| 2020 | -$12.8K | — |